Metabolic
Patients with metabolic diseases, including chronic and diabetic kidney disease, type 1 and type 2 diabetes, metabolic dysfunction-associated steatohepatitis, and obesity, present unique recruitment challenges to drug developers. Finding, engaging and recruiting patient populations facing these high-risk indications requires experience and precision.
Why Trialmed for metabolic clinical trials?
The demands of participating in a metabolic clinical trial can be overwhelming to patients living with metabolic diseases. Fortunately, we know what it takes to recruit and retain the participants your trial needs to succeed. Our on-site investigators understand the metabolic disease patient journey, enabling us to provide a top-tier patient experience. By matching patients with nearby research sites and offering virtual office visits, pre-screening, and telehealth, our solutions ease patient and caregiver burdens by minimizing transportation challenges.
Other key Trialmed differentiators include:
Our continuous self-funded pre-pooling process allows us to assess metabolic parameters and medications
Just-in-time repeat evaluations at study start up
We offer a central dietitian for study-specific site staff support
Our relationships with local nephrologists enable us to appropriately refer patients with rare renal disease
Our experience.
18 studies
10 countries
1,863 screens
941 patients randomized